- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
August 2nd, 2007
Domestic anti-cancer drug major Dabur Pharma is finalising plans to enter Japan and China. The company has started the groundwork of filing drug applications and is scouting for potential pharma acquisitions in both the countries.
Dabur Pharma also plans to expand the range of products developed on its nanotechnology drug delivery system, christened ‘Nanoxel'. At the moment, it sells the popular anti-cancer drug ‘Paclitaxel' on this platform. "We also want to export this portfolio of drugs in US, Europe and South-east Asian markets," said Mr Vij.
|Related News Press|
Iran to hold intl. school on application of nanomaterials in medicine September 20th, 2016
Chains of nanogold – forged with atomic precision September 23rd, 2016
Nanotech Grants Options September 22nd, 2016
Coffee-infused foam removes lead from contaminated water September 21st, 2016
Keysight Technologies Begins Trading as Independent Company November 3rd, 2014